Omnicell

Yahoo Finance • 18 days ago

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise FORT WORTH, Texas, December 08, 2025--(BUSINESS WIRE)--Omnicell, Inc.... Full story

Yahoo Finance • 24 days ago

Medication Adherence Research Report 2025: Market to Reach $3.63 Billion by 2030, Driven by Rising Chronic Disease Burden, Aging Populations, and Growing Adoption of Digital Health Tools

Company Logo The Global Medication Adherence Market presents opportunities driven by the rising prevalence of chronic diseases, an aging population, and healthcare tech advances, notably AI integration. Challenges include high medication... Full story

Yahoo Finance • 2 months ago

Omnicell outlines raised 2025 revenue guidance to $1.177B-$1.187B as cloud platform gains traction

Earnings Call Insights: Omnicell (OMCL) Q3 2025 MANAGEMENT VIEW * Randall Lipps, Founder, Executive Chairman, President & CEO, announced "another strong quarter" for Omnicell, highlighting that "total revenues, non-GAAP EBITDA and non-... Full story

Yahoo Finance • 3 months ago

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 3 months ago

Implied FYX Analyst Target Price: $122

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 4 months ago

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma,... Full story

Yahoo Finance • 4 months ago

Omnicell appoints Baird Radford as Executive VP and CFO

* Omnicell (NASDAQ:OMCL [https://seekingalpha.com/symbol/OMCL]) announced on Monday the appointment [https://seekingalpha.com/pr/20210694-omnicell-appoints-baird-radford-as-executive-vice-president-and-chief-financial-officer] of Baird R... Full story

Yahoo Finance • 4 months ago

AI in Endoscopy: Industry Outlook Through 2025-2029 Featuring Strategic Analysis of 13 Market Players in Hospitals, Specialty Clinics, and ASCs

Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "AI in Endoscopy Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The AI in endoscopy market is projected to expand by USD 2.56 billion from 2024 to 2029, exhibiting a... Full story

Yahoo Finance • 4 months ago

Piper Sandler lowers Omnicell stock price target to $55 on tariff concerns

Investing.com - Piper Sandler reduced its price target on Omnicell (NASDAQ:OMCL) to $55.00 from $57.00 on Monday, while maintaining an Overweight rating on the healthcare technology company. Currently trading at $30.83, the stock remains... Full story

Yahoo Finance • 5 months ago

Wells Fargo raises Omnicell stock price target to $40 on reduced tariff impact

Investing.com - Wells Fargo raised its price target on Omnicell (NASDAQ:OMCL) to $40.00 from $37.00 on Monday, while maintaining an Overweight rating on the stock, citing a more favorable tariff outlook. Currently trading at $26.88 with... Full story

Yahoo Finance • 5 months ago

Benchmark reiterates Buy rating on Omnicell stock amid tariff uncertainties

Investing.com - Benchmark has reiterated its Buy rating and $40.00 price target on Omnicell (NASDAQ:OMCL), currently trading at $27.82, as the company navigates through tariff uncertainties with China. According to InvestingPro data, ana... Full story

Yahoo Finance • 5 months ago

MeridianLink Appoints Tech Veteran Denise Cox as Chief Customer Officer

MeridianLink Appoints Tech Veteran Denise Cox as Chief Customer Officer Cox will lead MeridianLink’s Services, Support and Customer Success teams to strengthen customer relationships and experience IRVINE, Calif., July 15, 2025--(BUSINES... Full story

Yahoo Finance • 5 months ago

Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025

FORT WORTH, Texas, July 14, 2025--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the second quarter 2025, before market open on T... Full story

Yahoo Finance • 5 months ago

Validea Kenneth Fisher Strategy Daily Upgrade Report - 7/12/2025

The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consi... Full story

Yahoo Finance • 6 months ago

Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 6 months ago

Nuvem Invests in Expanded Leadership to Strengthen the Customer Experience for Community Health Providers

Healthcare veterans from Omnicell, ReCept, Aesynt, and McKesson join leadership team to respond to market demand and deliver unified, mission-aligned pharmacy experiences SHARON HILL, Pa., July 09, 2025--(BUSINESS WIRE)--Nuvem, a leading... Full story

Yahoo Finance • 7 months ago

Why Omnicell (OMCL) Stock Is Trading Up Today

What Happened? Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 5.9% in the afternoon session after the company reported impressive preliminary second quarter 2025 and full-year profit guidance due to reduced tariffs on imp... Full story

Yahoo Finance • last year

Is Omnicell, Inc. (NASDAQ:OMCL) The Top Stock With Improving Technical Ratings According To Piper Sandler?

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Omnicell, Inc. (NASDAQ:OMCL) ranks among the list of stocks with improving technical rating according to Piper Sandl... Full story

Yahoo Finance • last year

Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer

Nnamdi Njoku has been appointed Executive Vice President and Chief Operating Officer of Omnicell, effective October 7, 2024. In this newly created role, Mr. Njoku will lead the Company’s global operations. (Photo: Business Wire) The Compa... Full story

Yahoo Finance • 2 years ago

Is Now The Time To Look At Buying Omnicell, Inc. (NASDAQ:OMCL)?

While Omnicell, Inc. (NASDAQ:OMCL) might not have the largest market cap around , it saw significant share price movement during recent months on the NASDAQGS, rising to highs of US$32.65 and falling to the lows of US$26.27. Some share pri... Full story